The Technical AnalystExchange: PNK Industry: Medical Instruments & Supplies
EKIMAS Corporation Price, Forecast, Insider, Ratings, Fundamentals & Signals
6.58% $0.850
America/New_York / 16 mai 2023 @ 15:31
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4.83 mill |
| EPS: | -1.410 |
| P/E: | -0.603 |
| Earnings Date: | Feb 17, 2020 |
| SharesOutstanding: | 5.68 mill |
| Avg Daily Volume: | 0.0021 mill |
| RATING 2023-05-16 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.603 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.603 | industry: PE -6.22 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.818 - 0.882 ( +/- 3.76%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-07-27 | Gk Partners Aps | Buy | 25 000 | Common Stock |
| 2023-07-14 | Gk Partners Aps | Buy | 278 618 | Common Stock |
| 2023-06-26 | Gk Partners Aps | Buy | 25 000 | Common Stock |
| 2023-06-20 | Gk Partners Aps | Buy | 2 500 000 | Common Stock |
| 2023-02-28 | Gk Partners Aps | Buy | 2 125 000 | Common Stock |
| INSIDER POWER |
|---|
| -9.08 |
| Last 99 transactions |
| Buy: 27 889 436 | Sell: 7 611 404 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.850 (6.58% ) |
| Volume | 0.0045 mill |
| Avg. Vol. | 0.0021 mill |
| % of Avg. Vol | 220.14 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ASNB
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ASNB
EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.